Prior to joining PrecisionMed, Inc. as its President and founder, Dr. Flax worked in the pharmaceutical industry in both the United States and United Kingdom. Dr. Flax has 15 years experience in clinical drug development as director of cardiovascular development at Pfizer, Warner Lambert and Beecham (UK). His experience includes designing and managing clinical research programs as well as extensive FDA experience including prosecuting new drug applications. Dr. Flax, while maintaining his position at PrecisionMed, has consulted for numerous US and European pharmaceutical companies and has represented them at FDA. Apart from the development of FDA submissions and regular FDA interactions, Dr. Flax has conducted several successful FDA Advisory committee meetings. Dr. Flax was trained in cardiology at St. Mary’s Hospital in London, UK, and holds a MB, ChB from the University of Cape Town, South Africa and membership of the Royal College of Physicians of the United Kingdom {MRCP (UK)}.

Dr. Meltzer received his B.A. from Cornell University in 1958, an M.A. in Chemistry from Harvard University in 1959, and his M.D. from Yale University School of Medicine in 1963. Dr. Meltzer received his psychiatric training at the Massachusetts Mental Health Center. Dr. Meltzer has been professor of psychiatry at the University of Chicago and Case Western Reserve University School of Medicine. Dr. Meltzer is currently Bixler Professor of Psychiatry and Pharmacology and Director of the Division of Psychopharmacology at the Vanderbilt University School of Medicine. Dr. Meltzer is recipient of the Daniel Efron Research Award of the ACNP, recently served as editor of Psychopharmacology: The Third Generation of Progress, co-editor of Neuropsychopharmacology, and past president of that group. Dr. Meltzer is director of the research grant review program for the National Alliance for Research in Schizophrenia and Depression (NARSAD). He has received the Noyes Prize of the Commonwealth of Pennsylvania, the Edward J. Sachar Award from Columbia University, the Lieber Prize from NARSAD, and the Stanley Dean Award of the American College of Psychiatry for his research on schizophrenia and the Gold Medal Award of the Society of Biological Psychiatry. Dr. Meltzer is on the editorial board of the Archives of General Psychiatry and 7 other scientific journals. Dr. Meltzer’s major research interests are the psychopharmacologic treatment of schizophrenia, the neurochemistry of schizophrenia, the mechanism of action of new antipsychotic drugs, pharmacoeconomics, and cognitive studies in schizophrenia.

Mr. Flax is Chief Operating Officer of PrecisionMed, Inc. Over the past 20 years he has held senior and executive level positions in major European corporations in Operations, Human Resources and Legal Services. For 9 years, he was a Senior Vice-President of a publicly traded British retailer where he was responsible for Worldwide Operations, Human Resources and Labor Law matters. He was previously, for 7 years, General Counsel and Head of Human Resources for a London based office equipment manufacturer and distributor. Mr. Flax is a Law Graduate of the University of Cape Town and formerly practiced as an Attorney of the Supreme Court of South Africa, specializing in corporate transactions and labor law.

Dr. Lotzof is board certified in anesthesiology and internal medicine and is contracted to perform clinical study related procedures for PrecisionMed. Dr. Lotzof received his MD from the University of the Witwatersrand in Johannesburg, South Africa, completed his Residency in internal medicine at Emory University, Atlanta, Georgia, his residency in anesthesia at the University of Chicago and his Fellowship in Cardiovascular Anesthesia at Texas Heart Institute in Houston Texas. He is a member of the American Society of Anesthesiologists. Dr. Lotzof practices anesthesia in the San Diego, CA area and has acted as Principal Investigator on a number of PrecisionMed initiated clinical studies.

Dr. Selati is a board certified anesthesiologist. She received her B.A. from Wesleyan University. Her medical degree is from Emory University. After a year in internal medicine and pediatrics at St. Vincent’s Hospital in Manhattan, Dr. Selati completed her anesthesia residency at New York University Medical Center. She followed with a fellowship in pediatric anesthesia at Harvard’s Boston Children’s Hospital. She joined Anesthesia Services Medical Group of San Diego in 1999 and continues to practice with this group. Dr. Selati is a member of the American Society of Anesthesiologists and has been voted by her peers as one of San Diego’s Top Doctors for the third time.

Ms. Marks is Senior Clinical Research Manager and Project Director at PrecisionMed. She is a Business graduate of Rhodes University, South Africa. Prior to joining PrecisionMed, she held senior administrative positions at IVAC Corporation, a medical device manufacturer and distributor.

Ms.Savra is Senior Clinical Research Manager at PrecisionMed. She has over 12 years of experience in managing clinical trials for various Contact Research and Site Management Organizations with particular experience in subject enrollment initiatives and regulatory affairs.

Ms. Lavery-Morrow manages Tissue Operations at the California Tissue Consortium, a division of PrecisionMed, Inc. She is a communications graduate of San Francisco State University and has 10 years experience in business development with a focus on building and developing client relationships. Her most recent experience before joining PrecisionMed was in marketing clinical services to the medical community.

Matt Harper is PrecisionMed’s laboratory technician and IT manager. His laboratory experience was obtained through his work at the University of Wisconsin Bacteriology Department at Madison as well as during training at the Promega Corporation Biotechnology Center. While studying at the University of Wisconsin, he worked in the IT department, supporting the network and computers for the Chancellor and Deans. In addition to his laboratory and IT responsibilities, Matt is part of the research subject enrollment team. He is currently studying through a transfer program for Technical Writing.